Did you know that atypical endometrial hyperplasia can carry up to a 50% risk of concurrent endometrial cancer? This condition, caused by hormonal imbalance, thickens the uterine lining and may progress if untreated. In this article, we will explore what endometrial hyperplasia is, its complications, and the most effective treatments to manage or prevent its progression.
The best treatment depends on the type of hyperplasia and whether a woman wishes to have children in the future.
Progestin can be administered in several forms:
This treatment usually continues for a minimum of six months. However, obese individuals may face a higher risk of relapse due to persistent hormonal imbalances. Despite progestin therapy, the risk of developing endometrial cancer remains significant, approximately 15% to 28%, according to studies published in PubMed and the NIH.
Endometrial hyperplasia is a condition where the lining of the uterus (endometrium) becomes abnormally thick. This occurs due to an imbalance between the hormones oestrogen and progesterone.
Generally, after ovulation, progesterone helps regulate the growth of the endometrium. However, when progesterone levels are low or absent and oestrogen remains unopposed, the endometrial lining can grow excessively, leading to hyperplasia.
In some cases, especially if left untreated, endometrial hyperplasia can progress to uterine cancer.
Endometrial hyperplasia is primarily caused by hormonal imbalance, particularly an excess of oestrogen without adequate progesterone. This imbalance leads to continued thickening of the endometrial lining, even when the body should be shedding it during menstruation.
In some cases, prolonged unopposed oestrogen exposure may eventually result in precancerous changes.
If untreated, endometrial hyperplasia can lead to serious complications. According to the World Health Organisation (WHO) and NHS, the risk of developing endometrial cancer varies by type:
This makes early diagnosis and regular monitoring essential.
The prognosis is generally favourable with early detection and appropriate treatment. Most women respond well to hormonal therapy, especially with progestin. To ensure the condition does not progress to cancer, doctors may recommend:
One major risk factor is excess weight. Studies indicate that women who are more than 50 pounds overweight are 10 times more likely to develop endometrial cancer than women with lower body weight (source: NIH and CDC).
You can take several steps to lower your risk of developing this condition:
Additionally, incorporating easily accessible Indian foods such as green leafy vegetables, whole grains, curd, and lentils can support hormonal balance and overall reproductive health.
Endometrial hyperplasia is a manageable condition when diagnosed early and treated effectively. Progestin-based therapy remains the most commonly recommended approach, while hysterectomy is reserved for severe or unresponsive cases. Maintaining a healthy weight, following up with your doctor regularly, and avoiding unnecessary hormone exposure can significantly reduce your risk.